Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List

$26.16 -0.29 (-1.10%)

As of 04:10 PM Eastern

What stocks does THNR hold?

The Amplify Weight Loss Drug & Treatment ETF (THNR) top stock holdings include Novo Nordisk A/S, Eli Lilly and Company, and Arrowhead Pharmaceuticals. The top 23 THNR holdings ordered by weight make up 100.01% of the total fund. THNR is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete THNR stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 23 THNR Holdings

Rank	Company	Current Price	Weight	Shares Held
1	NVO Novo Nordisk A/S	$45.91 -1.7%	9.95%	10,447
2	LLY Eli Lilly and Company	$1,182.24 -2.2%	9.21%	394
3	ARWR Arrowhead Pharmaceuticals	$86.64 +1.2%	5.35%	3,202
4	ABBV AbbVie	$249.20 -0.6%	5.37%	1,060
5	HIMS Hims & Hers Health	$28.15 -2.2%	4.53%	8,249
6	SRRK Scholar Rock	$52.52 -1.0%	4.96%	5,329
7	REGN Regeneron Pharmaceuticals	$803.48 -0.3%	5.14%	401
8	MRK Merck & Co., Inc.	$135.78 +0.2%	5.05%	1,971
9	AMGN Amgen	$415.21 -0.6%	5.08%	691
10	VKTX Viking Therapeutics	$33.19 +0.8%	4.91%	7,225
11	PFE Pfizer	$26.77 -0.1%	4.49%	9,361
12	KLRA Kailera Therapeutics	$17.94 -0.2%	1.98%	5,722
13	Innovent Biologics, Inc.	N/A	5.49%	24,500
14	CSPC Pharmaceutical Group Limited	N/A	5.45%	256,000
15	Roche Holding AG	N/A	5.12%	603
16	AstraZeneca PLC	N/A	4.44%	1,344
17	Chugai Pharmaceutical Co., Ltd.	N/A	4.34%	4,900
18	Zealand Pharma A/S	N/A	3.51%	4,040
19	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	N/A	2.14%	15,200
20	Hanmi Pharm. Co., Ltd.	N/A	2.09%	401
21	Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional Class	N/A	1.21%	61,890
22	OTHER ASSETS AND LIABILITIES	N/A	0.20%	198,727,840
23	US DOLLARS	N/A	0.00%	8

THNR Geographic Exposure

THNR's largest geographic exposure is United States at 66.7%, followed by Cayman Islands at 5.9%.

United States
66.7%
Cayman Islands
5.9%
Hong Kong
5.5%
Japan
4.4%
Denmark
4.0%
United Kingdom
4.0%
Korea, Republic of
2.1%

THNR Currency Exposure

THNR's largest currency exposure is USD at 70.4%, followed by HKD at 13.5%.

USD
70.4%
HKD
13.5%
JPY
4.4%
DKK
4.0%
KRW
2.1%

THNR Sector Exposure

THNR's largest sector exposure is Health Care at 90.3%.

Health Care
90.3%

THNR Industry Exposure

THNR's largest industry exposure is Biotechnology at 85.8%, followed by Health Care Providers & Services at 4.5%.

Biotechnology
85.8%
Health Care Providers & Services
4.5%

THNR Sub-Industry Exposure

THNR's largest sub-industry exposure is Biotechnology at 85.8%, followed by Health Care Services at 4.5%.

Biotechnology
85.8%
Health Care Services
4.5%

Related Companies and Tools

Related Companies

This page (NYSEARCA:THNR) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List